EUVIMEDEUVIMED entdecken
Crossref

Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients

Seung-Jun Lee, Yong-Joon Lee, Kyounghoon Lee, Deok-Kyu Cho, Yun-Hyeong Cho, Sung Gyun Ahn iD, Kyeong Ho Yun, Ji-Yong Jang, Seunghwan Kim, Yong Hoon Kim, Yong Hwan Park, Sung Uk Kwon und 18 weitere

New England Journal of Medicine · 29.08.2026

DOI: 10.1056/nejmoa2608533 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, online erschienen am 29.08.2026. Verfasst von Seung-Jun Lee und 29 weiteren Autor:innen. Beteiligte Einrichtung: Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Samjin Pharmaceutical, Chong Kun Dang Pharmaceutical, Cardiovascular Research Center, Seoul, Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Gachon University Gil Medical Center, Incheon, South Korea.
  • Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.
  • Myongji Hospital, Hanyang University College of Medicine, Goyang, South Korea.
  • Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, South Korea.
  • Wonkwang University Hospital, Iksan, South Korea.

ORCID-Profile: Sung Gyun Ahn, Eun-Seok Shin, Chul-Min Ahn, Jung-Sun Kim, Yangsoo Jang

Förderung

  • Samjin Pharmaceutical
  • Chong Kun Dang Pharmaceutical
  • Cardiovascular Research Center, Seoul, Korea

Zitieren

APA

Lee, S. J., Lee, Y. J., Lee, K., Cho, D. K., Cho, Y. H., Ahn, S. G., Yun, K. H., Jang, J. Y., Kim, S., Kim, Y. H., Park, Y. H., Kwon, S. U., Hur, S. H., Kang, T. S., Shin, E. S., Lee, J. B., Jeon, K. H., Kim, U., Kim, W. H., …, & A-CLOSE investigators (2026). Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2608533

Vancouver

Lee SJ, Lee YJ, Lee K, Cho DK, Cho YH, Ahn SG, et al. Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients. New England Journal of Medicine. 2026. doi:10.1056/nejmoa2608533

BibTeX
@article{Lee2026,
  author = {Lee, Seung-Jun and Lee, Yong-Joon and Lee, Kyounghoon and Cho, Deok-Kyu and Cho, Yun-Hyeong and Ahn, Sung Gyun and Yun, Kyeong Ho and Jang, Ji-Yong and Kim, Seunghwan and Kim, Yong Hoon and Park, Yong Hwan and Kwon, Sung Uk and Hur, Seung-Ho and Kang, Tae Soo and Shin, Eun-Seok and Lee, Jin Bae and Jeon, Ki-Hyun and Kim, Ung and Kim, Won Ho and Hong, Bum-Kee and Lee, Sang-Hyup and Hong, Sung-Jin and Ahn, Chul-Min and Kim, Jung-Sun and Ko, Young-Guk and Choi, Donghoon and Hong, Myeong-Ki and Jang, Yangsoo and Kim, Byeong-Keuk and A-CLOSE investigators, A-CLOSE investigators},
  title = {Clopidogrel or Dual Antiplatelet Therapy in High-Ischemic-Risk Patients},
  journal = {New England Journal of Medicine},
  year = {2026},
  doi = {10.1056/nejmoa2608533}
}
Kostenlos starten →